Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombosis in Newly Diagnosed Multiple Myeloma Patients: a Clinical Audit of Intermediate Dose Low Molecular Weight Heparin

NCT05541978 is registered in ClinicalTrials.gov with Catalina Codreanu as lead sponsor.

NCT NCT05541978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05541978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombosis in Newly Diagnosed Multiple Myeloma Patients: a Clinical Audit of Intermediate Dose Low Molecular Weight Heparin
Lead sponsor
Catalina Codreanu
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
March 1, 2023
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial thromboembolism, multiple myeloma, venous thromboembolism